RESEARCH TRIANGLE PARK – Durham health technology startup Clinetic has secured a Series A round of financing that the company said would accelerate its work in clinical trials technology and patient recruitment.

Sopris Capital, a Colorado-based venture capital firm with investments in health tech, led the round, announced Tuesday. Financial terms weren’t disclosed.

“We are thrilled to partner with an investor who shares our vision for modernizing clinical research,” said Tom Kaminski, Clinetic’s CEO and co-founder. “Our data-driven software platform streamlines highly manual activities for both health systems and life sciences companies to ultimately complete studies faster and advance new therapies to improve patient care.”Clinetic logo

Clinetic was spun out of Duke University in 2017 as a health tech company focused on linking hospital data with clinical studies. Its platform makes it possible for researchers to use data from hospital electronic health records (EHRs) to improve patient recruitment for clinical trials as well as gain more insights into the data.

Since raising a $6.4 million seed round in 2021, the company has added new health system customers. In February it announced its 10th academic medical center agreement. That total is now 12, representing more than 70 hospitals with a total of 2,500 care locations across 14 states. The company has 18 employees.

Clinetic said it would use the new round of financing for multiple purposes, including: accelerating patient recruitment and real-world data capabilities for clinical trials, deeper relationships with data-connected health systems, and more collaborations with life sciences companies.

(C) N.C. Biotech Center